Skip to main content

People

Mei-Yin Chen Polley, PhD

Dr. Polley’s primary research involves the design, conduct, and analysis of all phases of cancer clinical trials. She is the Head of the Statistics Division of NRG Oncology Statistics and Data Management Center (SDMC) as well as the Lead Statistician for the Brain Tumor Committee of NRG Oncology, a National Cancer Institute sponsored member of the national clinical trials network group. Previously, Dr. Polley held positions as an Assistant Professor in the Department of Neurosurgery at UCSF, a mathematical statistician in the Biometric Research Program at the National Cancer Institute (NCI), and an Associate Professor of Biostatistics in the Department of Quantitative Health Sciences at Mayo Clinic. Dr. Polley has nearly two decades of experience as a cancer clinical trial biostatistician. Her statistical methods research has spanned a variety of areas including early-phase clinical trial designs, biomarker reproducibility, innovative group sequential methods for biomarker validation, prognostic and predictive modeling, and design and analysis of biomarker-based clinical trials. Her expertise has led to invitations to influential positions as a statistical advisor including the Federal Advisory Committee of the US Department of Veterans Affairs (VA), the Scientific Committee of American Society of Clinical Oncology (ASCO), and the Scientific Committee of the CNS Clinical Trials conference, among many others. She has been competitively elected to numerous national scientific governing or advisory bodies including the NCI’s National Clinical Trials Network (NCTN) Steering Committees for trials in lymphoma and head and neck cancer.